Important Business Aspects of Immuno-Oncology: Issues and Controversies
PharmaTalkRadio20 Kesä 2017

Important Business Aspects of Immuno-Oncology: Issues and Controversies

Originally recorded during a panel session at the 2017's Immuno-Oncology 360°, Mark Simon of Torreya Partners moderates the conversation around issues, controversies, and other important business aspects of IO. He's joined by IO360° lead advisor and SVP at GSK, Dr Axel Hoos, Dr Robert Ang of Neon Therapeutics, Dr Jeffrey Bockman from Defined Health, Dr Jeffrey Legos from Novartis Pharmaceuticals, and Dr Chandra Ramanathan at Bayer Healthcare. Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-tiedetta-vai-tarinaa
docemilia
rss-duodecim-lehti
utelias-mieli
rss-kasvikutsut
rss-astetta-parempi-elama-podcast
radio-antro
rss-hereilla
rss-ammamafia
rss-tervetta-skeptisyytta
hippokrateen-vastaanotolla
rss-ranskaa-raakana
rss-radplus
filocast-filosofian-perusteet
mielipaivakirja
rss-bios-podcast
rss-ylistys-elaimille